Magnesium isoglycyrrhizinate injection is a hepatoprotective agent with anti-inflammatory and hepatocyte membrane protection effects, which is used for the treatment of chronic viral hepatitis and improvement of abnormal liver function. Its side effects include hypokalemia, panic and dizziness. Magnesium isoglycyrrhizinate injection is a kind of hepatoprotective drug, with anti-inflammatory, hepatocyte protection, improving liver function, etc. It is commonly used in the treatment of chronic viral hepatitis, and can also be used to improve liver function for liver function abnormality or hepatic insufficiency caused by other diseases. Adverse reactions such as hypokalemia, increased blood pressure, sodium retention, edema, weight gain, panic, dizziness, etc. may occur with incremental or prolonged use of Magnesium Isoglycyrrhizinate Injection. This drug is contraindicated in patients with severe hypokalemia, hypernatremia, hypertension, heart failure, and renal failure. Magnesium Isoglycyrrhizinate Injection needs to be used under the guidance of a professional doctor and should be avoided on its own.